Detalhe da pesquisa
1.
Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions.
Cell
; 185(20): 3789-3806.e17, 2022 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36179670
2.
Microbiome analyses of blood and tissues suggest cancer diagnostic approach.
Nature
; 579(7800): 567-574, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32214244
3.
First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors.
Cancer Immunol Immunother
; 72(7): 2443-2458, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37016126
4.
A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer.
BMC Cancer
; 23(1): 708, 2023 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37507657
5.
ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment.
Proc Natl Acad Sci U S A
; 117(33): 20159-20170, 2020 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32747553
6.
Patient Blood Type Is Associated With Response to Immune Checkpoint Blockade in Metastatic Cancer.
Oncologist
; 27(9): e739-e747, 2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35816018
7.
A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: High-grade neuroendocrine neoplasm cohort.
Cancer
; 127(17): 3194-3201, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33882143
8.
Phase Ib Study of Crizotinib plus Pembrolizumab in Patients with Previously Untreated Advanced Non-Small Cell Lung Cancer with ALK Translocation.
Oncologist
; 25(7): 562-e1012, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32048771
9.
Landscape of Immune-Related Pneumonitis in Cancer Patients with Asthma Being Treated with Immune Checkpoint Blockade.
Oncology
; 98(2): 123-130, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31665718
10.
GABABR-Mediated Paraneoplastic Limbic Encephalitis Due To Thymic Small Cell Carcinoma.
J Gen Intern Med
; 34(8): 1658-1661, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31062226
11.
Next generation predictive biomarkers for immune checkpoint inhibition.
Cancer Metastasis Rev
; 36(1): 179-190, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27873079
12.
Incidence of Thyroid Function Test Abnormalities in Patients Receiving Immune-Checkpoint Inhibitors for Cancer Treatment.
Oncologist
; 23(10): 1236-1241, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29769383
13.
Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego Moores Cancer Center.
Oncologist
; 22(6): 631-637, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28550027
14.
Immuno-Oncology: New Insights into Targets and Therapies.
Surg Oncol Clin N Am
; 33(2): 265-278, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38401909
15.
Validation of an Updated Algorithm to Identify Patients With Incident Non-Small Cell Lung Cancer in Administrative Claims Databases.
JCO Clin Cancer Inform
; 8: e2300165, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38502111
16.
Robustness of cancer microbiome signals over a broad range of methodological variation.
Oncogene
; 43(15): 1127-1148, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38396294
17.
Anti-tumor activity of a novel monoclonal antibody, NPC-1C, optimized for recognition of tumor antigen MUC5AC variant in preclinical models.
Cancer Immunol Immunother
; 62(6): 1011-9, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23591984
18.
CD73 Inhibitor Oleclumab Plus Osimertinib in Previously Treated Patients With Advanced T790M-Negative EGFR-Mutated NSCLC: A Brief Report.
J Thorac Oncol
; 18(5): 650-656, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36641093
19.
Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response.
Nat Commun
; 14(1): 2744, 2023 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37173324
20.
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.
Cancer Discov
; 13(7): 1556-1571, 2023 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37068173